CN106432198A - 一种制备伏立康唑拆分中间体的方法 - Google Patents
一种制备伏立康唑拆分中间体的方法 Download PDFInfo
- Publication number
- CN106432198A CN106432198A CN201610811521.4A CN201610811521A CN106432198A CN 106432198 A CN106432198 A CN 106432198A CN 201610811521 A CN201610811521 A CN 201610811521A CN 106432198 A CN106432198 A CN 106432198A
- Authority
- CN
- China
- Prior art keywords
- voriconazole
- acetone
- sulfonic acid
- racemic modification
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
- C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/19—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/60—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
- C07C2603/66—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供了一种新的伏立康唑左旋樟脑磺酸盐的制备方法,该方法包括将伏立康唑外消旋体和左旋樟脑磺酸溶解在水和丙酮组成混合溶剂中,降温析晶,过滤烘干得到伏立康唑左旋樟脑磺酸盐。本发明通过调整拆分溶剂,有效降低了生产成本。
Description
技术领域
本发明涉及一种制备伏立康唑中间体的方法。
背景技术
伏立康唑(voriconazole,VRC,UK109496)是美国辉瑞公司在氟康唑基础上合成的一种新型抗真菌药,主要用于进行性、有致命危险的免疫损害患者。由于伏立康唑抗真菌谱广、抗菌效力强,安全性好,且国内市场对抗真菌药物的需求增长迅速,因此市场前景巨大。
伏立康唑,其化学名为:(2R,3S)-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇,结构式如式Ⅰ所示:
伏立康唑外消旋体作为一种重要的中间体,化学名为:(2R,3S/2S,3R)-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇,结构式如式Ⅱ所示:
从伏立康唑的结构可以看出其有两个手性中心,可能存在四种异构体,对于异构体的分离一般有两种方法,第一种是在反应过程中手性诱导,这种方法一般需要采用手性催化剂,成本比较高,不利于大规模的工业生产,第二种是采用手性拆分剂进行拆分,手性拆分剂的回收比较简便,一般可以反复使用,这种方法在工业生产中经常采用。
在经过一系列的预处理后,我们可以得到伏立康唑的外消旋体,即(2R,3S)构型和(2S,3R)构型的混合物。伏立康唑的外消旋体需要一步拆分得到伏立康唑,即(2R,3S)-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇。
专利EP2444398A2中公开了伏立康唑外消旋体的拆分方法,使用的拆分剂是左旋樟脑磺酸,拆分溶剂是甲醇和丙酮的混合溶剂,合成路线如下:
上述拆分溶剂存在以下两个问题:
1.甲醇和丙酮这两种溶剂沸点比较接近,且挥发性都比较强,很难进行分离,因此,拆分物的溶剂回收是一个很大的问题,增加了生产成本,同时也不符合环保生产的要求。
2.在拆分过程中,拆分溶剂的使用量非常大,产能较低,严重影响的了拆分物的大规模生产。
为了解决这两个问题,我们对伏立康唑的拆分方法进行了改进,开发了一种新型的拆分方法。
发明内容
本发明提供了一种伏立康唑左旋樟脑磺酸盐的制备方法,包括如下步骤:将伏立康唑外消旋体和左旋樟脑磺酸溶解在水和丙酮组成混合溶剂中,降温析晶,过滤烘干得到伏立康唑左旋樟脑磺酸盐。
上述制备方法中,其中丙酮和水的体积比为100:1-1:100,优选为15:1-5:1。所述混合溶剂的使用量相对于伏立康唑外消旋体为10-30mL/g,优选为10-15mL/g。析晶温度为0-40℃,优选为15-30℃。
本发明得到的伏立康唑左旋樟脑磺酸盐可以根据现有技术的方法,加碱游离即得到伏立康唑。
本发明有意义的技术效果是通过调整拆分溶剂,降低生产成本,提高产能,极具工业生产价值。
具体实施方式
实施例1:
伏立康唑外消旋体(9g),左旋樟脑磺酸(6g),丙酮(150mL),水(30mL),升温至50℃,溶液澄清,自然降温至0℃,在0℃搅拌2小时,过滤,HPLC检测,ee%=99.3%,产率30.1%。
实施例2:
伏立康唑外消旋体(9g),左旋樟脑磺酸(6g),丙酮(150mL),水(15mL),升温至50℃,溶液澄清,自然降温至25℃,在25℃搅拌2小时,过滤,HPLC检测,ee%=99.7%,产率36.6%。
实施例3:
伏立康唑外消旋体(15g),左旋樟脑磺酸(10g),丙酮(150mL),水(15mL),升温至50℃,溶液澄清,自然降温至20℃,在20℃搅拌2小时,过滤,HPLC检测,ee%=99.7%,产率40.4%。
实施例4:
伏立康唑外消旋体(15g),左旋樟脑磺酸(10g),丙酮(150mL),水(10mL),升温至50℃,溶液澄清,自然降温至25℃,在25℃搅拌2小时,过滤,HPLC检测,ee%=99.8%,产率37.5%。
对比实施例:
伏立康唑外消旋体(15.1g)溶于丙酮(288mL)中,加入左旋樟脑磺酸(8.51g)的甲醇(96mL)溶液,升温至50℃,溶液澄清,缓慢降温至20℃,并在20℃搅拌18小时,过滤,HPLC检测,ee%=99.8%,产率35%。
Claims (8)
1.一种伏立康唑左旋樟脑磺酸盐的制备方法,包括如下步骤:将伏立康唑外消旋体和左旋樟脑磺酸溶解在水和丙酮组成混合溶剂中,降温析晶,过滤烘干得到伏立康唑左旋樟脑磺酸盐。
2.根据权利要求1所述的方法,其中丙酮和水的体积比为100:1-1:100。
3.根据权利要求2所述的方法,其中丙酮和水的体积比为15:1-5:1。
4.根据权利要求1或2所述的方法,所述混合溶剂的使用量相对于伏立康唑外消旋体为10-30mL/g。
5.根据权利要求4所述的方法,所述混合溶剂的使用量相对于伏立康唑外消旋体为10-15mL/g。
6.根据权利要求1或2所述的方法,拆分物的析晶温度为0-40℃。
7.根据权利要求6所述的方法,拆分物的析晶温度为15-30℃。
8.一种伏立康唑的合成方法,包括将根据权利要求1所述的方法制备得到的伏立康唑左旋樟脑磺酸盐,加碱游离得到伏立康唑。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610811521.4A CN106432198B (zh) | 2016-09-08 | 2016-09-08 | 一种制备伏立康唑拆分中间体的方法 |
EP16915563.7A EP3511326B1 (en) | 2016-09-08 | 2016-11-10 | Method for preparing voriconazole l-camphorsulphonate and voriconazole |
PCT/CN2016/105312 WO2018045629A1 (zh) | 2016-09-08 | 2016-11-10 | 一种制备伏立康唑左旋樟脑磺酸盐以及伏立康唑的方法 |
US16/330,692 US11919884B2 (en) | 2016-09-08 | 2016-11-10 | Method for preparing voriconazole L-camphorsulphonate and voriconazole |
ES16915563T ES2911289T3 (es) | 2016-09-08 | 2016-11-10 | Procedimiento para preparar L canforsulfonato de voriconazol y voriconazol |
EP22154723.5A EP4019509A1 (en) | 2016-09-08 | 2016-11-10 | Method for preparing voriconazole l-camphorsulphonate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610811521.4A CN106432198B (zh) | 2016-09-08 | 2016-09-08 | 一种制备伏立康唑拆分中间体的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106432198A true CN106432198A (zh) | 2017-02-22 |
CN106432198B CN106432198B (zh) | 2022-10-21 |
Family
ID=58164369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610811521.4A Active CN106432198B (zh) | 2016-09-08 | 2016-09-08 | 一种制备伏立康唑拆分中间体的方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US11919884B2 (zh) |
EP (2) | EP3511326B1 (zh) |
CN (1) | CN106432198B (zh) |
ES (1) | ES2911289T3 (zh) |
WO (1) | WO2018045629A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111440152A (zh) * | 2020-05-18 | 2020-07-24 | 浙江诚意药业股份有限公司 | 一种伏立康唑的制备方法 |
CN113354625A (zh) * | 2021-06-16 | 2021-09-07 | 安徽普利药业有限公司 | 伏立康唑的合成工艺 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013096A1 (en) * | 2005-06-30 | 2007-02-01 | Msn Laboratories Limited | Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole) |
CN101765595A (zh) * | 2007-08-06 | 2010-06-30 | 韩美药品株式会社 | 制备伏立康唑的方法 |
WO2010095145A1 (en) * | 2009-02-17 | 2010-08-26 | Glenmark Generics Limited | Process for the preparation of voriconazole |
CN102516233A (zh) * | 2011-12-09 | 2012-06-27 | 北京联本医药化学技术有限公司 | 生产伏立康唑的新方法 |
CN102807563A (zh) * | 2012-08-27 | 2012-12-05 | 南京华威医药科技开发有限公司 | 伏立康唑及其中间体的制备方法 |
CN104884450A (zh) * | 2012-10-15 | 2015-09-02 | 辉瑞爱尔兰制药公司 | 制备伏立康唑及其类似物的方法 |
CN105503834A (zh) * | 2015-12-23 | 2016-04-20 | 浙江华海药业股份有限公司 | 一种伏立康唑中间体的合成方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9516121D0 (en) * | 1995-08-05 | 1995-10-04 | Pfizer Ltd | Organometallic addition to ketones |
CN1473825A (zh) * | 2002-08-07 | 2004-02-11 | 张文祥 | 制备伏立康唑的方法 |
WO2007132354A2 (en) | 2006-02-01 | 2007-11-22 | Medichem, S.A. | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof |
AR061889A1 (es) * | 2006-07-13 | 2008-10-01 | Medichem Sa | Proceso mejorado para la preparacion de voriconazol |
WO2009084029A2 (en) | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol |
KR101109215B1 (ko) | 2009-06-17 | 2012-01-30 | 보령제약 주식회사 | 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법 |
-
2016
- 2016-09-08 CN CN201610811521.4A patent/CN106432198B/zh active Active
- 2016-11-10 EP EP16915563.7A patent/EP3511326B1/en active Active
- 2016-11-10 US US16/330,692 patent/US11919884B2/en active Active
- 2016-11-10 EP EP22154723.5A patent/EP4019509A1/en active Pending
- 2016-11-10 WO PCT/CN2016/105312 patent/WO2018045629A1/zh unknown
- 2016-11-10 ES ES16915563T patent/ES2911289T3/es active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013096A1 (en) * | 2005-06-30 | 2007-02-01 | Msn Laboratories Limited | Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole) |
CN101765595A (zh) * | 2007-08-06 | 2010-06-30 | 韩美药品株式会社 | 制备伏立康唑的方法 |
WO2010095145A1 (en) * | 2009-02-17 | 2010-08-26 | Glenmark Generics Limited | Process for the preparation of voriconazole |
CN102516233A (zh) * | 2011-12-09 | 2012-06-27 | 北京联本医药化学技术有限公司 | 生产伏立康唑的新方法 |
CN102807563A (zh) * | 2012-08-27 | 2012-12-05 | 南京华威医药科技开发有限公司 | 伏立康唑及其中间体的制备方法 |
CN104884450A (zh) * | 2012-10-15 | 2015-09-02 | 辉瑞爱尔兰制药公司 | 制备伏立康唑及其类似物的方法 |
CN105503834A (zh) * | 2015-12-23 | 2016-04-20 | 浙江华海药业股份有限公司 | 一种伏立康唑中间体的合成方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111440152A (zh) * | 2020-05-18 | 2020-07-24 | 浙江诚意药业股份有限公司 | 一种伏立康唑的制备方法 |
CN111440152B (zh) * | 2020-05-18 | 2022-09-27 | 浙江诚意药业股份有限公司 | 一种伏立康唑的制备方法 |
CN113354625A (zh) * | 2021-06-16 | 2021-09-07 | 安徽普利药业有限公司 | 伏立康唑的合成工艺 |
CN113354625B (zh) * | 2021-06-16 | 2023-09-26 | 安徽普利药业有限公司 | 伏立康唑的合成工艺 |
Also Published As
Publication number | Publication date |
---|---|
EP3511326A1 (en) | 2019-07-17 |
ES2911289T3 (es) | 2022-05-18 |
EP3511326A4 (en) | 2019-08-07 |
US11919884B2 (en) | 2024-03-05 |
WO2018045629A1 (zh) | 2018-03-15 |
EP4019509A1 (en) | 2022-06-29 |
CN106432198B (zh) | 2022-10-21 |
US20210276980A1 (en) | 2021-09-09 |
EP3511326B1 (en) | 2022-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2444398A2 (en) | Novel intermediates of voriconazole and preparation method of voriconazole using the same | |
EP3526189B1 (en) | Process for the preparation of (1r,3r)- and (1s,3s)-2,2-dihalo-3-(substituted phenyl)cyclopropanecarboxylic acids | |
CN105503834B (zh) | 一种伏立康唑中间体的合成方法 | |
EP3915981B1 (en) | Method for preparation of efinaconazole in ionic liquid medium | |
WO2008025852A1 (de) | Rückgewinnung von bis(diarylphenol)-liganden bei der herstellung von isopulegol | |
CN105348209A (zh) | 一种抗心衰药lcz696的制备方法 | |
CN106432198A (zh) | 一种制备伏立康唑拆分中间体的方法 | |
CN104311502A (zh) | 从茚虫威混合体中分离提纯s体茚虫威的方法 | |
CN103319406A (zh) | 1-(4-甲氧苄基)-八氢-异喹啉的拆分 | |
CA2974180A1 (en) | Crystalline forms of efinaconazole | |
EP3555042B1 (en) | Process for preparation of isoproterenol hydrochloride | |
US20040176637A1 (en) | Process for preparation of 2-chlorophenylglycine derivatives and enantiomerically separation | |
CN109803961B (zh) | (r)-5-(3,4-二氟苯基)-5-[(3-甲基-2-氧代吡啶-1(2h)-基)甲基]咪唑烷-2,4-二酮的制造方法及用于该制造的中间体 | |
EP3339300B1 (en) | Method for preparing thienyl alanine having optical activity | |
CN107337628B (zh) | 一种制备左乙拉西坦的方法 | |
WO2009142521A1 (en) | Process for preparation of enantiomerically pure (s)-1-phenyi-1,2,3,4- tetrahydroisoquinoline | |
CN104876812A (zh) | 制备盐酸舍曲林中间体及杂质的方法 | |
CN102863354B (zh) | 一种动态拆分2‑氨基丁酰胺的方法 | |
KR20100091249A (ko) | 광학 활성 2,2'-비페놀 유도체 및 그 제조 방법 | |
CN109400489B (zh) | 一种盐酸甲氯芬酯的制备方法 | |
US10081597B2 (en) | Process for preparation of dexmethylphenidate hydrochloride | |
WO2022078796A1 (en) | PROCESS FOR THE PREPARATION OF α-ALKYL-2-(TRIFLUOROMETHYL)-BENZYL ALCOHOLS | |
WO2015004686A2 (en) | A process for purification of efavirenz and intermediates thereof using chromatographic methods | |
CN105732481A (zh) | 高纯度苯磺酸左旋氨氯地平的制备方法 | |
DE10317878A1 (de) | Verfahren zur Herstellung von alpha-methylierten Cystein und Serin-Derivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |